跳至主要内容
临床试验/IRCT20200610047715N1
IRCT20200610047715N1已完成3 期

The effect of zinc sulfate and folic acid on endocrine indices, CRP and lipid profile in women with polycystic ovary syndrome in 2017-18.

Rafsanjan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Oligoovulation or / and anovulation
  • Clinical symptoms (Ferriman-Gallwey score=6 or Acne or Seborrhoeic) or biochemical hyperandrogenism
  • Evidence of polycystic ovaries on ultrasound

排除标准

  • Hyperprolactinoma
  • Thyroid disease
  • Cardiovascular diseases
  • Kidney-liver and neoplastic diseases
  • Type 2 diabetes
  • Pregnancy or breastfeeding
  • Absorption disorders
  • Use of drugs such as anti-diabetic drugs, anti-obesity drugs, diuretics, OCP, steroid and hormonal drugs (at least 3-6 months) and drugs that interfere with folic acid (perimetamine, aspirin, carbamazepine, chloramphenicol, chlorothiazide, conjugated estrogens, forge , Hydrochlorothiazide, Methotrexate, Phenytoin, Phenobarbital, Sulfamethoxazole, Salicylate)

研究者

相似试验